Featuring the standoff over open access fees in Germany, a go-to resource for research on Open Science topics and what’s what with Creative Commons licences.
Featuring the launch of ChemRxiv, an introduction to open access and an overview of preprint resources.
Use of preprints is increasing rapidly, with the number of preprints posted to repositories each month almost doubling in the past year
Featuring data on how much article processing charges cost universities, an overview of transparency tools, the July workstream reports and how authors can push for open science without disadvantaging their careers.
Summary report from the Open Pharma workstream meetings in July
With CRediT, ORCID and Publons integrated into Editorial Manager®, we aim for these transparency tools to be easy, standard steps in the publishing process
Featuring a study on the state of open access, Elsevier’s shift in strategy with the acquisition of Bepress and a survey of open access resources.
Open access publishing is on the rise, providing both opportunities and challenges for publishers, academics, funding bodies and pharma. However, academic authors collaborating with pharma prefer to publish in journals with the highest impact factor possible, and open access is not necessarily the authors’ priority. In our Open Pharma workstreams, we have identified a strong … Continue reading Open access education: time for a new approach?